Impax Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Impax Asset Management's VRTX Position: Q2 2018 in Review
Impax Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q2 2018, buying an estimated $46.8K and bringing the position to 2,998 shares worth $510K. The position accounts for 0.03% of the portfolio, ranked #171.
Impax Asset Management first reported a position in VRTX in Q2 2017 and has held it in 5 quarters since. 690 funds tracked by Wall St. Rank hold VRTX as of Q2 2018.
- Impax Asset Management held 2,998 shares of Vertex Pharmaceuticals worth $510K as of Q2 2018.
- Impax Asset Management bought 302 Vertex Pharmaceuticals shares in Q2 2018, an estimated $46.8K.
- Vertex Pharmaceuticals made up 0.03% of Impax Asset Management's portfolio in Q2 2018, its #171 holding.
- Impax Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 5 quarters since.
- 690 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2018.
Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.